FDA Approved: HALOPERIDOL DECANOATE — Supplemental Application (Mylan Institutional LLC)

View source ↗

Summary

FDA approves a supplemental application for HALOPERIDOL DECANOATE from Mylan Institutional LLC (a long-acting injectable antipsychotic).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Drugs mentioned

• HALOPERIDOL DECANOATE (Haloperidol decanoate)

Snippet

SUPPL AP for HALOPERIDOL DECANOATE (HALOPERIDOL DECANOATE)